M.Steven Piver

408 total citations
16 papers, 299 citations indexed

About

M.Steven Piver is a scholar working on Reproductive Medicine, Surgery and Obstetrics and Gynecology. According to data from OpenAlex, M.Steven Piver has authored 16 papers receiving a total of 299 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Reproductive Medicine, 7 papers in Surgery and 7 papers in Obstetrics and Gynecology. Recurrent topics in M.Steven Piver's work include Ovarian cancer diagnosis and treatment (8 papers), Intraperitoneal and Appendiceal Malignancies (6 papers) and Endometrial and Cervical Cancer Treatments (5 papers). M.Steven Piver is often cited by papers focused on Ovarian cancer diagnosis and treatment (8 papers), Intraperitoneal and Appendiceal Malignancies (6 papers) and Endometrial and Cervical Cancer Treatments (5 papers). M.Steven Piver collaborates with scholars based in United States. M.Steven Piver's co-authors include Gamal H. Eltabbakh, Trudy R. Baker, Fernando O. Recio, Elizabeth A. Repasky, David F. Silver, Deborah L. Driscoll, Ronald E. Hempling, Leslie E. Blumenson, Shashikant Lele and James Fanning and has published in prestigious journals such as Cancer, Gynecologic Oncology and International Journal of Gynecology & Obstetrics.

In The Last Decade

M.Steven Piver

16 papers receiving 290 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M.Steven Piver United States	12	163	111	94	64	51	16	299
Paul C. Tseng United States	7	200 1.2×	140 1.3×	72 0.8×	96 1.5×	36 0.7×	9	342
Ya-Li Zhai Japan	10	133 0.8×	217 2.0×	42 0.4×	47 0.7×	95 1.9×	11	362
G. C. Torre Italy	5	153 0.9×	56 0.5×	78 0.8×	69 1.1×	44 0.9×	8	325
Audrey P. Garrett United States	9	269 1.7×	230 2.1×	83 0.9×	77 1.2×	32 0.6×	15	467
B.J. Monk United States	11	191 1.2×	135 1.2×	104 1.1×	135 2.1×	72 1.4×	57	367
Heather Foster United Kingdom	6	233 1.4×	121 1.1×	70 0.7×	99 1.5×	99 1.9×	11	421
Jennifer McLachlan United Kingdom	10	116 0.7×	61 0.5×	58 0.6×	113 1.8×	45 0.9×	21	280
Ferdinando Coronetta Italy	7	214 1.3×	392 3.5×	107 1.1×	113 1.8×	42 0.8×	11	495
M. Lapresa Italy	10	294 1.8×	199 1.8×	97 1.0×	113 1.8×	42 0.8×	16	420
Giuseppa Maltese Italy	11	215 1.3×	203 1.8×	84 0.9×	115 1.8×	85 1.7×	25	394

Countries citing papers authored by M.Steven Piver

Since Specialization

Citations

This map shows the geographic impact of M.Steven Piver's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.Steven Piver with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.Steven Piver more than expected).

Fields of papers citing papers by M.Steven Piver

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.Steven Piver. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.Steven Piver. The network helps show where M.Steven Piver may publish in the future.

Co-authorship network of co-authors of M.Steven Piver

This figure shows the co-authorship network connecting the top 25 collaborators of M.Steven Piver. A scholar is included among the top collaborators of M.Steven Piver based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.Steven Piver. M.Steven Piver is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Silver, David F., et al.. (2000). Flt-3 Ligand Inhibits Growth of Human Ovarian Tumors Engrafted in Severe Combined Immunodeficient Mice. Gynecologic Oncology. 77(3). 377–382. 19 indexed citations

Silver, David F., et al.. (1999). Effects of IL-12 on Human Ovarian Tumors Engrafted into SCID Mice. Gynecologic Oncology. 72(2). 154–160. 23 indexed citations

Piver, M.Steven, et al.. (1999). Analysis of Failed and Complicated Laparoscopy on a Gynecologic Oncology Service. Gynecologic Oncology. 74(3). 477–482. 11 indexed citations

Piver, M.Steven, et al.. (1998). Prolonged Disease-Free Survival by Maintenance Chemotherapy among Patients with Recurrent Platinum-Sensitive Ovarian Cancer. Gynecologic Oncology. 71(2). 190–195. 18 indexed citations

Eltabbakh, Gamal H., M.Steven Piver, Ronald E. Hempling, et al.. (1998). Correlation between Extreme Drug Resistance Assay and Response to Primary Paclitaxel and Cisplatin in Patients with Epithelial Ovarian Cancer. Gynecologic Oncology. 70(3). 392–397. 32 indexed citations

Eltabbakh, Gamal H. & M.Steven Piver. (1998). Extraovarian primary peritoneal carcinoma.. PubMed. 12(6). 813–9; discussion 820, 825. 42 indexed citations

Recio, Fernando O., et al.. (1998). Five-Year Survival after Second-Line Cisplatin-Based Intraperitoneal Chemotherapy for Advanced Ovarian Cancer. Gynecologic Oncology. 68(3). 267–273. 25 indexed citations

Piver, M.Steven, Nachimuthu Natarajan, Trudy R. Baker, et al.. (1993). Predictive value of serum CA125 following optimal cytoreductive surgery during weekly cisplatin induction therapy for advanced ovarian cancer. Journal of Surgical Oncology. 54(1). 38–44. 4 indexed citations

Piver, M.Steven, et al.. (1993). A phase II study of weekly cisplatin followed by cisplatin and ifosfamide in advanced or recurrent cervical carcinoma. Cancer. 71(7). 2245–2249. 14 indexed citations

10.

Fanning, James & M.Steven Piver. (1992). Serial CA 125 levels during chemotherapy for metastatic or recurrent endométrial cancer. International Journal of Gynecology & Obstetrics. 37(2). 158–158. 15 indexed citations

11.

Baker, Trudy R., et al.. (1991). Prospective Trial of Cisplatin, Adriamycin, and Dacarbazine in Metastatic Mixed Mesodermal Sarcomas of the Uterus and Ovary. American Journal of Clinical Oncology. 14(3). 246–250. 29 indexed citations

12.

Rose, Peter G. & M.Steven Piver. (1990). Primary resection of vaginal metastases with the Cavitron ultrasonic surgical aspirator in stage III endometrial carcinoma. Gynecologic Oncology. 39(3). 264–265. 4 indexed citations

13.

Piver, M.Steven, et al.. (1990). Cisplatin-based chemotherapy for stage II ovarian adenocarcinoma: A preliminary report. Gynecologic Oncology. 39(3). 249–252. 12 indexed citations

14.

Goldrosen, Martin H., et al.. (1990). Comparison of cisplatin and carboplatin cytotoxicity in human ovarian cancer cell lines using the MTT assay. Gynecologic Oncology. 39(2). 119–122. 26 indexed citations

15.

Baker, Trudy R., M.Steven Piver, Shashikant B. Lele, & Yoshiaki Tsukada. (1988). Stage I uterine adenosarcoma: A report of six cases. Journal of Surgical Oncology. 37(2). 128–132. 11 indexed citations

16.

Piver, M.Steven, Joseph J. Barlow, Shashikant Lele, & R Yazigi. (1979). Adriamycin in localized and metastatic uterine sarcomas. Journal of Surgical Oncology. 12(3). 263–265. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact